1. Home
  2. SNN

SNN

Smith & Nephew SNATS Inc.

Logo Smith & Nephew SNATS Inc.

Health Care

Industrial Specialties

Nasdaq

as 04-22-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Founded: 1856 Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 10.4B IPO Year: 1999
Target Price: $33.00 AVG Volume (30 days): 951.1K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield: 3.08% Dividend Payout Frequency: Semi-Annual
EPS: 0.60 EPS Growth: -49.58
52 Week Low/High: $21.53 - $33.09 Next Earning Date: 02-27-2024
Revenue: $5,549,000,000 Revenue Growth: 6.47%
Revenue Growth (this year): 7.19% Revenue Growth (next year): 5.16%

Share on Social Networks: